Keywords: expanded, use, tap, prevacid, pharmaceutical, joint, venture

Expanded use for TAP's Prevacid

Article | 05 July 2004

Print This

TAP Pharmaceutical, a joint venture between US firm Abbott Laboratoriesand Japan's Takeda, says that the US Food and Drug Administration ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in